erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Altomare G et al. Treatment of bullous pemphigoid with erythromycin: a reappraisal. 1999 Oct-Nov Eur J Dermatol pmid:10610238
Czeizel AE et al. A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. 1999 Nov-Dec Reprod. Toxicol. pmid:10613401
Urmösi J [Thrombophlebitis of the sinus cavernosus]. 1975 Stomatol DDR pmid:1061410
National guideline for the management of Chlamydia trachomatis genital tract infection. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). 1999 Sex Transm Infect pmid:10616372
National guideline for the management of non-gonococcal urethritis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases) 1999 Sex Transm Infect pmid:10616373
National guideline for the management of early syphilis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). 1999 Sex Transm Infect pmid:10616379
National guideline for the management of lymphogranuloma venereum. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). 1999 Sex Transm Infect pmid:10616382
National guideline for the management of chancroid. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). 1999 Sex Transm Infect pmid:10616383
Chieppa DM et al. Effects of erythromycin on human colonic circular muscle in idiopathic chronic constipation. 2000 Eur. J. Clin. Invest. pmid:10620004
Novikova SI et al. Introduction of a mini-gene encoding a five-amino acid peptide confers erythromycin resistance on Bacillus subtilis and provides temporary erythromycin protection in Proteus mirabilis. 2000 FEMS Microbiol. Lett. pmid:10620668
Desaki M et al. Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells. 2000 Biochem. Biophys. Res. Commun. pmid:10623585
Kdesh A et al. Effect of erythromycin on myocardial repolarization in patients with community-acquired pneumonia. 1999 South. Med. J. pmid:10624910
Gallardo MA and Thomas I Hypersensitivity reaction to erythromycin. 1999 Cutis pmid:10626100
Lagrou K et al. Macrolide resistance in Belgian Streptococcus pneumoniae. 2000 J. Antimicrob. Chemother. pmid:10629023
García Sánchez MJ et al. [Bacterial resistances]. 1999 Aten Primaria pmid:10630037
Sullivan S et al. Stevens-Johnson syndrome secondary to erythromycin. 1999 Ann Pharmacother pmid:10630839
Trinkle R Comment: evaluation of the clinical and financial impact of intravenous erythromycin therapy in hospitalized patients. 1999 Ann Pharmacother pmid:10630842
Puri SK and Singh N Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys. 2000 Exp. Parasitol. pmid:10631075
Weston WL and Morelli JG Steroid rosacea in prepubertal children. 2000 Arch Pediatr Adolesc Med pmid:10632252
Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999. 1999 MMWR Morb. Mortal. Wkly. Rep. pmid:10634345
Nasrin D et al. Antibiotic resistance in Streptococcus pneumoniae isolated from children. 1999 J Paediatr Child Health pmid:10634983
Martínez-Maldonado M Postinfectious glomerulonephritis. 2000 Am. J. Kidney Dis. pmid:10636819
Wu YJ Highlights of semi-synthetic developments from erythromycin A. 2000 Curr. Pharm. Des. pmid:10637376
Bajic S et al. Analysis of erythromycin by liquid chromatography/mass spectrometry using involatile mobile phases with a novel atmospheric pressure ionization source. 2000 Rapid Commun. Mass Spectrom. pmid:10637421
Gisby J and Bryant J Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. 2000 Antimicrob. Agents Chemother. pmid:10639346
Brueggemann AB et al. In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. 2000 Antimicrob. Agents Chemother. pmid:10639382
Honma Y et al. Effect of erythromycin on Shigella infection of Caco-2 cells. 2000 FEMS Immunol. Med. Microbiol. pmid:10640609
Sharma PK et al. Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial. 2000 J. Am. Acad. Dermatol. pmid:10642679
Santos R et al. Bacillary angiomatosis by Bartonella quintana in an HIV-infected patient. 2000 J. Am. Acad. Dermatol. pmid:10642694
Lebwohl M et al. Clinically significant therapeutic interactions for the practicing dermatologist. 1999 Adv Dermatol pmid:10643493
Heidenreich A et al. Gastroparesis after retroperitoneal surgery successfully treated with erythromycin. 2000 J. Urol. pmid:10647677
Medhus AW et al. Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel. 2000 Aliment. Pharmacol. Ther. pmid:10651665
Mackinnon AM The problem of intrahepatic cholestasis. 1975 Aust N Z J Med pmid:1065291
Tsutsumi M et al. Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats. 2000 Carcinogenesis pmid:10657965
Allevi P et al. A new convenient transformation of erythromycin A into clarithromycin. 1999 Bioorg. Med. Chem. pmid:10658579
Nakahara S et al. Bronchial amyloidosis successfully treated with low-dose long-term erythromycin therapy. 1999 Kurume Med J pmid:10659597
From the Centers for Disease Control and Prevention. Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999. 2000 JAMA pmid:10659863
Descheemaeker P et al. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. 2000 J. Antimicrob. Chemother. pmid:10660498
Wilkinson B et al. Novel octaketide macrolides related to 6-deoxyerythronolide B provide evidence for iterative operation of the erythromycin polyketide synthase. 2000 Chem. Biol. pmid:10662692
Tang L et al. Formation of functional heterologous complexes using subunits from the picromycin, erythromycin and oleandomycin polyketide synthases. 2000 Chem. Biol. pmid:10662693
Moutard I et al. In vitro effects of spiramycin and dirithromycin on IL1 beta production by human LPS-stimulated mononuclear cells. 1999 Sep-Oct Therapie pmid:10667098
Mordi MN et al. Acid-catalyzed degradation of clarithromycin and erythromycin B: a comparative study using NMR spectroscopy. 2000 J. Med. Chem. pmid:10669574
Munroe CO and Lazarus TL Prevention of infective endocarditis. 1976 Dent J pmid:1067255
Gibson J et al. Oral staphylococcal mucositis: A new clinical entity in orofacial granulomatosis and Crohn's disease. 2000 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:10673652
Holen S Antibiotics used traditionally in periodontal therapy. 1976 J. Periodontol. pmid:1067412
Biddle JW and Thornsberry C In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae. 1979 Antimicrob. Agents Chemother. pmid:106776
Kohri K et al. Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages. 2000 Eur. Respir. J. pmid:10678622
Poyart C et al. Characterization of the Tn916-like transposon Tn3872 in a strain of abiotrophia defectiva (Streptococcus defectivus) causing sequential episodes of endocarditis in a child. 2000 Antimicrob. Agents Chemother. pmid:10681362
Tang X and Cheng D [The value of erythromycin pleurodesis in the treatment of malignant pleural effusions]. 1997 Hua Xi Yi Ke Da Xue Xue Bao pmid:10683963
Berg TG et al. Ureaplasma/Mycoplasma-infected amniotic fluid: pregnancy outcome in treated and nontreated patients. 1999 J Perinatol pmid:10685238
Fail PA et al. Comparative effects of quinacrine and erythromycin in adult female rats: a nonsurgical sterilization study. 2000 Fertil. Steril. pmid:10685548
Yamano K et al. Quantitative prediction of metabolic inhibition of midazolam by erythromycin, diltiazem, and verapamil in rats: implication of concentrative uptake of inhibitors into liver. 2000 J. Pharmacol. Exp. Ther. pmid:10688631
Noerr B Erythromycin. 1999 Neonatal Netw pmid:10690102
Thwaites RT and Frost JA Drug resistance in Campylobacter jejuni, C coli, and C lari isolated from humans in north west England and Wales, 1997. 1999 J. Clin. Pathol. pmid:10690169
Vardy SJ and Rose GE Prevention of cellulitis after open lacrimal surgery: a prospective study of three methods. 2000 Ophthalmology pmid:10690832
Hill BC et al. A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents. 2000 J. Clin. Microbiol. pmid:10699011
Timosca S et al. [Bacteremia following tooth extractions]. 1976 Rev Stomatol Chir Maxillofac pmid:1070098
Suri A et al. Effects of CYP3A inhibition on the metabolism of cilostazol. 1999 Clin Pharmacokinet pmid:10702888
Bernabéu JA et al. Microbiological bioassay of erythromycin thiocyanate: optimisation and validation. 1999 J Pharm Biomed Anal pmid:10703990
Brisaert M et al. Investigation of the chemical stability of an erythromycin-tretinoin lotion by the use of an optimization system. 2000 Int J Pharm pmid:10704802
Faoagali JL et al. Sensitivity of 941 beta haemolytic streptococci to antibacterial drugs. 1976 N. Z. Med. J. pmid:1070586
Karam B et al. Ergotism precipitated by erythromycin: a rare case of vasospasm. 2000 Eur J Vasc Endovasc Surg pmid:10706847
Sazykin IuO et al. [Ketolides--erythromycin derivatives with activity against macrolide-resistant bacteria]. 2000 Antibiot. Khimioter. pmid:10707799
MacLaren R et al. Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study. 2000 Crit. Care Med. pmid:10708180
Krecic-Shepard ME et al. Gender-specific effects on verapamil pharmacokinetics and pharmacodynamics in humans. 2000 J Clin Pharmacol pmid:10709150
Moussa F et al. Erythromycin eye ointment: effect on gastrointestinal motility. 2000 Am. J. Gastroenterol. pmid:10710093
Dewan NA et al. Acute exacerbation of COPD: factors associated with poor treatment outcome. 2000 Chest pmid:10712989
López de Blanc S et al. Bacillary angiomatosis affecting the oral cavity. Report of two cases and review. 2000 J. Oral Pathol. Med. pmid:10718405
Chepkwony HK et al. Separation of erythromycin and related substances on base-deactivated reversed-phase silica gel columns. 2000 J Chromatogr A pmid:10722081
Portillo A et al. Macrolide resistance genes in Enterococcus spp. 2000 Antimicrob. Agents Chemother. pmid:10722498
Brophy DF et al. Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers. 2000 Antimicrob. Agents Chemother. pmid:10722500
Ono T et al. Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes. 2000 Antimicrob. Agents Chemother. pmid:10722517
Strigl S et al. In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae. 2000 Antimicrob. Agents Chemother. pmid:10722526
Gracey HE et al. Preparation and in vitro antibacterial activity of 6-O-methylerythromycin D. 1999 J. Antibiot. pmid:10726932
Smith AJ et al. Prokinetic effect of erythromycin after colorectal surgery: randomized, placebo-controlled, double-blind study. 2000 Dis. Colon Rectum pmid:10733114
Karchmer AW et al. Single-antibiotic therapy for streptococcal endocarditis. 1979 JAMA pmid:107335
Potts JM et al. Association of chronic urinary symptoms in women and Ureaplasma urealyticum. 2000 Urology pmid:10736488
Dubini F et al. [Research on erythromycin and spiramycin in saliva]. 1976 Dent Cadmos pmid:1073735
Or YS et al. Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens. 2000 J. Med. Chem. pmid:10737737
Orrett FA Methicillin resistance among Trinidadian isolates of community and hospital strains of Staphylococcus aureus and their patterns of resistance to non-beta-lactam antibiotics. 1999 Jpn. J. Infect. Dis. pmid:10738361
Erythromycin use linked to pyloric stenosis. 2000 Am J Nurs pmid:10738394
Nielsen K et al. Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin. 2000 Diagn. Microbiol. Infect. Dis. pmid:10744366
Simango C and Mvududu F Penicillin resistant Streptococcus pneumoniae isolates in Harare, Zimbabwe. 1999 Cent Afr J Med pmid:10746390
Martinez JA et al. Diffuse panbronchiolitis in Latin America. 2000 Am. J. Med. Sci. pmid:10746829
Davies TA et al. Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies. 2000 J. Clin. Microbiol. pmid:10747123
Luna VA et al. A novel multiresistant Streptococcus pneumoniae serogroup 19 clone from Washington State identified by pulsed-field gel electrophoresis and restriction fragment length patterns. 2000 J. Clin. Microbiol. pmid:10747146
Furneri PM et al. Genetic basis of natural resistance to erythromycin in Mycoplasma hominis. 2000 J. Antimicrob. Chemother. pmid:10747837
Faure C et al. Effect of meal and intravenous erythromycin on manometric and electrogastrographic measurements of gastric motor and electrical activity. 2000 Dig. Dis. Sci. pmid:10749328
Hoppe JE Neonatal pertussis. 2000 Pediatr. Infect. Dis. J. pmid:10749468
Zhao DM et al. Effect of erythromycin on ATP-induced intracellular calcium response in A549 cells. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10749750
Clanton LJ and Bender J Refractory spinal cord injury induced gastroparesis: resolution with erythromycin lactobionate, a case report. 1999 J Spinal Cord Med pmid:10751126
Murata T et al. [Serum concentration of erythromycin suppositories and clinical use in oral surgery (author's transl)]. 1975 Nihon Koku Geka Gakkai Zasshi pmid:1075289
Solensky R et al. Clinical approach to penicillin-allergic patients: a survey. 2000 Ann. Allergy Asthma Immunol. pmid:10752918
Petrakis IE et al. Induced-hyperglycemia attenuates erythromycin-induced acceleration of hypertonic liquid-phase gastric emptying in type-I diabetic patients. 1999 Dig Dis pmid:10754365
Brenciaglia MI et al. Helicobacter pylori: cultivability and antibiotic susceptibility of coccoid forms. 2000 Int. J. Antimicrob. Agents pmid:10755237
Bellaïche G et al. [Non-hemorrhagic and erythematous colitis associated with Klebsiella oxytoca after treatment with erythromycin]. 2000 Gastroenterol. Clin. Biol. pmid:10755860
Stamm LV and Bergen HL A point mutation associated with bacterial macrolide resistance is present in both 23S rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate. 2000 Antimicrob. Agents Chemother. pmid:10755994
Bassetti M et al. Erythromycin resistance in Streptococcus pyogenes in Italy. 2000 Mar-Apr Emerging Infect. Dis. pmid:10756153
Majima Y et al. [Study on a rat tracheal mucus producing model]. 2000 Jpn J Antibiot pmid:10756441
Nakaya Y et al. [Suppressive action of erythromycin on cultured tracheal epithelial cell chloride channel activated by interferon-gamma]. 2000 Jpn J Antibiot pmid:10756442